CCI Photonics boosted by £100,000 support
A life sciences firm has received £100,000 backing.
CCI Photonics has been supported by LYVA Labs to develop a urinary tract infection test.
Bosses say the apparatus will carry out a 15-minute test before identifying the correct antibiotics for treatment.
They add current methods for testing bacteria causing urinary tract infections can take up to 72 hours.
Dr Carlos Meza, CCI Photonics chief executive, said: “LYVA Labs' investment will help speed up the process of bringing our device to market, strengthen our quality management system as we prepare for regulatory approval, and develop our route-to-market strategy.”
CCI Photonics recently moved to Sci-Tech Daresbury, and has partnered with the Liverpool School of Tropical Medicine to further validate its technology.
It is taking part in the LYVA Labs’ incubator programme.
Akshay Bhatnagar, LYVA Labs’ head of investments, added: “We are excited to support Carlos and the team to develop this game-changing technology with the potential to help urinary tract infection sufferers all over the world and combat the scourge of antimicrobial resistance.”
Want your business, product or service to be seen regionally and nationally? Bdaily helps you get your story in front of the right audience, every day. Find out how Bdaily can help →
Join more than 55,000 subscribers by signing up to our daily bulletin each morning here.
Why being ‘work-ready’ matters more than ever
The North's future doesn't end at Manchester
Exit or legacy? Why every owner needs a plan
Who speaks up for SMEs when giants get bigger?
The true value of HR in an AI-driven working world
What new business rates guidance means for pubs
Business success starts with people investment
It's time to confront the digital poverty crisis
Why a business exit is no longer all or nothing
Culture is the foundation for sustainable growth
Business must help young people take root in work
Purposeful procurement for long-term growth